The efficacy and safety of Epimedium in the treatment of primary osteoporosis: a systematic review and meta-analysis.
- 2025-09-19
- Systematic Review · n = 10
- Frontiers in medicine 12
- Xian-Quan Zhang
- Zhen-Hui Hua
- Chu-Jia Huang
- Hai-Yun Chen
- Zong-Ren Hu
- Mei-Ren Zhang
- Jun Liu
- PubMed: 41048931
- DOI: 10.3389/fmed.2025.1675160
- High evidence
- Clinical
Serum alkaline phosphatase (ALP) was significantly reduced (MD = -8.78; 95% CI: -12.80, -4.77; <0.0001)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes